tert-butyl (3S,4E)-3-amino-4-(carbamoylhydrazinylidene)butanoate | 444608-34-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert-butyl (3S,4E)-3-amino-4-(carbamoylhydrazinylidene)butanoate
• CAS: 444608-34-8
• 化学式: C₉H₁₈N₄O₃
• 分子量: 230.267
• InChiKey: SYDQNOWIHWGBBF-XDZJJNIASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.1
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  120
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  tert-butyl (3S,4E)-3-amino-4-(carbamoylhydrazinylidene)butanoate 在 四丁基氟化铵 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 1-羟基苯并三唑一水物 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 20.0h， 生成 4-semicarbazone-3(S)-[2-(2-oxo-5-phenyl-3(R)-(4-methoxyphenylcarbamoyloxymethyl)-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)acetylamino]butyric acid tert-butyl ester
  参考文献：
  名称：

  Novel Peptidomimetic Cysteine Protease Inhibitors as Potential Antimalarial Agents

  摘要：

  The synthesis of a new class of peptidomimetics 1a-j, based on a 1,4-benzodiazepine scaffold and on a C-terminal aspartyl aldehyde building block, is described. Compounds 1a-j provided significant inhibitory activity against falcipains 2A and 2B (FP-2A and FP-2B), two cysteine proteases from Plasmodium falciparum.

  DOI：

  10.1021/jm060405f
• 作为产物：
  描述：

  tert-butyl (3S,4E)-4-(carbamoylhydrazinylidene)-3-(9H-fluoren-9-ylmethoxycarbonylamino)butanoate 在 二乙胺 作用下， 以 乙腈 为溶剂， 反应 2.0h， 生成 tert-butyl (3S,4E)-3-amino-4-(carbamoylhydrazinylidene)butanoate
  参考文献：
  名称：

  Novel Peptidomimetic Cysteine Protease Inhibitors as Potential Antimalarial Agents

  摘要：

  The synthesis of a new class of peptidomimetics 1a-j, based on a 1,4-benzodiazepine scaffold and on a C-terminal aspartyl aldehyde building block, is described. Compounds 1a-j provided significant inhibitory activity against falcipains 2A and 2B (FP-2A and FP-2B), two cysteine proteases from Plasmodium falciparum.

  DOI：

  10.1021/jm060405f

文献信息

• (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
  申请人：Idun Pharmaceuticals, Inc.

  公开号：US20030232788A1

  公开（公告）日：2003-12-18

  This invention is directed to novel (substituted)acyl dipeptidyl ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

  这项发明涉及新型（取代）酰基二肽酶ICE/ced-3家族抑制剂化合物。该发明还涉及含有这些化合物的药物组合物，以及将这些组合物用于治疗患有炎症、自身免疫和神经退行性疾病的患者，预防缺血性损伤，并保护即将进行移植手术的器官。
• Discovery of small molecule protease inhibitors by investigating a widespread human gut bacterial biosynthetic pathway
  作者：Benjamin A. Schneider、Emily P. Balskus

  DOI：10.1016/j.tet.2018.03.043

  日期：2018.6

  clusters that generate these metabolites has far outpaced identification of the molecules themselves. Here, we used an isolation-independent approach to access the probable products of a nonribosomal peptide synthetase-encoding gene cluster from Ruminococcus bromii, an abundant gut commensal bacterium. By combining bioinformatics with in vitro biochemical characterization of biosynthetic enzymes, we predicted

  来自人类微生物群的天然产物可能介导宿主的健康和疾病。但是，发现产生这些代谢产物的生物合成基因簇的发现远远超过了分子本身的鉴定。在这里，我们使用了一种独立于分离的方法来访问来自丰富的肠道共生细菌布鲁米球菌的非核糖体肽合成酶编码基因簇的可能产物。通过将生物信息学与生物合成酶的体外生化特征相结合，我们预测该途径可能会产生N-酰化的二肽醛（瘤胃肽素）。然后，我们使用化学合成方法来获得公认的反刍肽素支架。这些化合物中的几种抑制金黄色葡萄球菌内蛋白酶GluC（SspA / V8蛋白酶）。这种蛋白酶的同系物存在于肠道共生和机会病原体以及人类肠道的基因组中。总的来说，这项工作揭示了不依赖分离的方法可快速获取生物活性化合物的实用性，并突出了肠道微生物天然产物在靶向肠道微生物蛋白酶方面的潜在作用。
• A practical synthesis of ( S ) 3- tert -Butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic acid methyl ester as a conformationally restricted dipeptido-Mimetic for caspase-1 (ICE) inhibitors
  作者：David J. Lauffer、Michael D. Mullican

  DOI：10.1016/s0960-894x(02)00107-5

  日期：2002.4

  A simple and versatile method for the synthesis of (S) 3-tert-butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic acid methyl ester (4), a dipeptide mimetic, has been developed. The regioselective functionalization of the N1 and N5 ring nitrogens and the C3 amino group is demonstrated in the synthesis of an interleukin-1beta converting enzyme inhibitor 13. (C) 2002 Elsevier Science Ltd. All rights reserved.
• US7297714B2
  申请人：——

  公开号：US7297714B2

  公开（公告）日：2007-11-20
• Novel Peptidomimetic Cysteine Protease Inhibitors as Potential Antimalarial Agents
  作者：Nicola Micale、Alan P. Kozikowski、Roberta Ettari、Silvana Grasso、Maria Zappalà、Jong-Jin Jeong、Ajay Kumar、Manjit Hanspal、Athar H. Chishti

  DOI：10.1021/jm060405f

  日期：2006.6.1

  The synthesis of a new class of peptidomimetics 1a-j, based on a 1,4-benzodiazepine scaffold and on a C-terminal aspartyl aldehyde building block, is described. Compounds 1a-j provided significant inhibitory activity against falcipains 2A and 2B (FP-2A and FP-2B), two cysteine proteases from Plasmodium falciparum.